Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
81,000
Employees81,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
81,000
Employees81,000

PFE Key Statistics

Market cap
146.03B
Market cap146.03B
Price-Earnings ratio
13.97
Price-Earnings ratio13.97
Dividend yield
6.51%
Dividend yield6.51%
Average volume
73.56M
Average volume73.56M
High today
$26.50
High today$26.50
Low today
$25.67
Low today$25.67
Open price
$26.45
Open price$26.45
Volume
36.58M
Volume36.58M
52 Week high
$30.43
52 Week high$30.43
52 Week low
$20.92
52 Week low$20.92

PFE News

Simply Wall St 1d
How the Drug-Pricing Deal and a 10.8% Surge Are Shaping Pfizer's 2025 Outlook

If you have been weighing whether to buy, hold, or sell Pfizer right now, you are not alone. The company’s shares have seen some ups and downs that can leave ev...

How the Drug-Pricing Deal and a 10.8% Surge Are Shaping Pfizer's 2025 Outlook
Nasdaq 1d
PFE February 2026 Options Begin Trading

Investors in Pfizer Inc (Symbol: PFE) saw new options become available today, for the February 2026 expiration. One of the key data points that goes into the pr...

PFE February 2026 Options Begin Trading
The Motley Fool 1d
Down 50%, Should You Buy the Dip on Pfizer?

Pfizer's stock price is down materially from its 2021 highs, but it is also up notably from its April 2025 lows. Pfizer (PFE -0.45%) has a huge 6.3% dividend y...

Down 50%, Should You Buy the Dip on Pfizer?

Analyst ratings

60%

of 25 ratings
Buy
36%
Hold
60%
Sell
4%

More PFE News

TipRanks 1d
Pfizer’s Strategic Acquisitions and Growth Potential: A Buy Recommendation by Evan Seigerman

Pfizer, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Evan Seigerman from BMO Capital maintained a Buy rating on the...

Nasdaq 1d
TrumpRx Brings Pfizer Into the Green—Is It a Buy?

Pfizer (NYSE: PFE) is no stranger to income investors. The drugmaker, famous for treatments including Lipitor, Viagra, and Zoloft, has now increased its dividen...

TrumpRx Brings Pfizer Into the Green—Is It a Buy?
Nasdaq 2d
Worried About Tariffs? 2 Safe Haven Stocks to Buy on the Dip With $500

Key Points Investors have feared that U.S. import tariffs may hurt companies’ earnings growth -- and weigh on stock performance. The following two players not...

Worried About Tariffs? 2 Safe Haven Stocks to Buy on the Dip With $500
24/7 Wall St. 2d
Energy Transfer, Pfizer, and Realty Income Offer 5%+ Yields With Strong Payout Coverage

Home Investing 3 Stocks Yielding 5% and More to Buy and Hold for the Next 5 Years Investing 3 Stocks Yielding 5% and More to Buy and Hold for the Next 5 Years...

Energy Transfer, Pfizer, and Realty Income Offer 5%+ Yields With Strong Payout Coverage
Sherwood News 2d
Can pharma companies put tariff threats behind them?

Big Pharma may have gotten Trump off its back for now. But are drug prices coming down? For the past nine months, pharmaceutical companies have been paralyzed...

Can pharma companies put tariff threats behind them?
Nasdaq 2d
Great News for Pfizer Stock Investors

Pfizer (NYSE: PFE) made a deal with the White House to avoid paying tariffs on imported products. Where to invest $1,000 right now? Our analyst team just revea...

Great News for Pfizer Stock Investors
TipRanks 2d
Pfizer’s Mixed Financial Outlook: Hold Rating Amid Growth Potential and Challenges

Pfizer, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Chris Schott from J.P. Morgan maintained a Hold rating on the stock...

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.